What Are The Estimated Market Size And CAGR For The Phacoemulsification System Market Between 2026 And 2030?
The phacoemulsification system market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising cataract prevalence, aging population growth, adoption of phaco techniques, ophthalmic infrastructure expansion, surgeon preference for minimally invasive tools.
The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in outpatient eye surgeries, technological innovation in ultrasound systems, rising demand for premium IOLs, expansion in emerging markets, increasing vision care awareness. Major trends in the forecast period include advanced fluidics control systems, minimally invasive cataract surgery adoption, high precision ultrasonic energy delivery, faster surgical procedure times, improved patient safety outcomes.
Claim Your Free Report Sample Today:
Which Drivers Are Expected To Support The Future Advancement Of The Phacoemulsification System Market?
The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification system helps minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Welcome to GOV.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system market.
Which Segment Categories Are Influencing The Growth Trajectory Of The Phacoemulsification System Market?
The phacoemulsification system market covered in this report is segmented –
1) By Product Type: Standalone Phacoemulsification Systems, Portable Phacoemulsification Systems
2) By Application: Cataract Surgery, Refractive Lens Exchange (RLE), Secondary Lens Removal Procedures
3) By End-User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Standalone Phacoemulsification Systems: Ultrasonic Handpiece Units, Control Console Units, Fluid Management Units, Illumination Module Units
2) By Portable Phacoemulsification Systems: Battery Powered Units, Compact Console Units, Handheld Operation Units, Mobile Surgical Kits
What Key Market Trends Are Contributing To The Ongoing Development Of The Phacoemulsification System Market?
Major companies operating in the phacoemulsification system market are focusing on integration of femtosecond laser technology such as the novel fluidics concept to maintain stable intraocular pressure (IOP), to enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Novel fluidics concept refers to an advanced fluid management technology in phacoemulsification systems that precisely regulates the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, unveiled Virtuoso a novel dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system features a novel fluidics concept that maintains target intraocular pressure (IOP) throughout all surgical steps, a hybrid flow and pressure pump design for superior chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to enhance precision and surgical efficiency.
Which Organizations Are Considered Principal Leaders In The Phacoemulsification System Market?
Major companies operating in the phacoemulsification system market are Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, MTP Medical Technical Products
Get Your In-Depth Phacoemulsification System Market Report Now:
Which Geographical Areas Are Expected To Witness The Most Substantial Phacoemulsification System Market Expansion Ahead?
North America was the largest region in the phacoemulsification system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phacoemulsification system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment